(Q34136521)

31 July 2017

1 reference

title

Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105. (English)

1 reference

ORCID Public Data File 2021

31 July 2017

1 reference

1 reference

1 reference

author name string

C Li

1

1 reference

31 July 2017

B Guo

2

1 reference

31 July 2017

C Bernabeu

3

1 reference

31 July 2017

S Kumar

4

1 reference

31 July 2017

publication date

1 February 2001

1 reference

Microscopy Research and Technique

31 July 2017

published in

1 reference

31 July 2017

volume

52

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

437-449

1 reference

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Expression of endoglin mRNA and protein in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Smads as transcriptional co-modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Transcriptional regulation of the transforming growth factor beta 1 promoter by v-src gene products is mediated through the AP-1 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Serum levels of the TGF-beta receptor are increased in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Transforming growth factor-B3 protects murine small intestinal crypt stem cells and animal survival after irradiation, possibly by reducing stem-cell cycling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

A murine model of hereditary hemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Tamoxifen induces TGF-beta 1 activity and apoptosis of human MCF-7 breast cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Effects of a variety of cytokines and inducing agents on vascular permeability factor mRNA levels in U937 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Transforming growth factor-beta1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Assignment of the human endoglin gene (END) to 9q34-->qter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Characterization of the mouse transforming growth factor-beta 1 promoter and activation by the Ha-ras oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

TGF-beta isoforms are differentially expressed in increasing malignant grades of HaCaT keratinocytes, suggesting separate roles in skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

The types II and III transforming growth factor-beta receptors form homo-oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

The functions of thrombospondin and its involvement in physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Phosphorylation of the human-transforming-growth-factor-beta-binding protein endoglin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Endoglin modulates cellular responses to TGF-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Role of transforming growth factor beta3 in lymphatic metastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Defective angiogenesis in mice lacking endoglin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Betaglycan presents ligand to the TGF beta signaling receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

The transforming growth factor-beta family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

TGF-beta signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Transcriptional control by the TGF-beta/Smad signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

TGF-β Regulates Production of Growth Factors and TGF-β by Human Peripheral Blood Monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Transforming growth factor beta1 modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Transforming growth factor-beta: latent forms, binding proteins and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Growth of MDA-MB-231 cell line: different effects of TGF-beta(1), EGF and estradiol depending on the length of exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Transforming growth factor-beta1 stimulates the synthesis of basement membrane proteins laminin, collagen type IV and entactin in rat liver sinusoidal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

The promise of anti-angiogenic cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Generational analysis reveals that TGF-beta1 inhibits the rate of angiogenesis in vivo by selective decrease in the number of new vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Mammary tumor suppression by transforming growth factor beta 1 transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Endothelial cell apoptosis in capillary network remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Identification of a structural domain that distinguishes the actions of the type 1 and 2 isoforms of transforming growth factor beta on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; correlations with cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

The mechanism for the activation of latent TGF-beta during co-culture of endothelial cells and smooth muscle cells: cell-type specific targeting of latent TGF-beta to smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Signaling inputs converge on nuclear effectors in TGF-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

The role of thrombospondin-1 in tumor progression and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Differential effects of transforming growth factor-beta on the expression of collagenase-1 and collagenase-3 in human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Regulation of Smad signalling by protein associations and signalling crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Arrested lung morphogenesis in transgenic mice bearing an SP-C-TGF-beta 1 chimeric gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Fighting cancer by attacking its blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Modes of inhibition of protein kinase C by triphenylacrylonitrile antiestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Transforming growth factors beta1, beta2, and beta3 and their receptors are differentially regulated during normal and impaired wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

The pro domain of pre-pro-transforming growth factor beta 1 when independently expressed is a functional binding protein for the mature growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Vascular endothelial growth factor is increased in devascularized rat islets of Langerhans in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Genetic control of the circulating concentration of transforming growth factor type beta1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Hereditary hemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Opposing effects of heparin with TGF-beta or aFGF during repair of a mechanical wound of human endothelium. Influence of cAMP on cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Expression of transforming growth factor-beta (TGF-beta) isoforms in osteosarcomas: TGF-beta3 is related to disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

21 January 2018

CD 105 and angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Reorganization of endothelial cord-like structures on basement membrane complex (Matrigel): involvement of transforming growth factor beta 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Effects of tamoxifen and interferon-beta or the combination on tumor-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Stimulation of fibroblast proliferation by thrombospondin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Long-term expression of transforming growth factor TGF beta 1 in mouse skin after localized beta-irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Expression of transforming growth factor type III receptor in vascular endothelial cells increases their responsiveness to transforming growth factor beta 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Transforming growth factor-beta: biological function and chemical structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Antiangiogenic radioimmunotherapy of human solid tumors in SCID mice using (125)I-labeled anti-endoglin monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

The fibronectin production is increased by thrombospondin via activation of TGF-beta in cultured human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Analyses of microsatellite instability and the transforming growth factor-beta receptor type II gene mutation in sporadic breast cancer and their correlation with clinicopathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Transforming growth factor beta 1 induces apoptotic cell death in cultured human umbilical vein endothelial cells with down-regulated expression of bcl-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Expression of endoglin in the transition between psoriatic uninvolved and involved skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Irradiation induces up-regulation of E9 protein (CD105) in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

Evidence for role of transforming growth factor-beta in RRR-alpha-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G

10.1002/1097-0029(20010215)52:4<437::AID-JEMT1029>3.0.CO;2-G

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference